泼尼松联合甲氨喋啶治疗对系统性红斑狼疮患者炎症因子及免疫球蛋白表达水平的影响<sup>*</sup>

doi:10.3969/j.issn.1671-7171.2021.01.006

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1164 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To investigate the clinical effect of prednisone combined with methotrexate on the expression of interleukin-17 (IL-17), interleukin-23 (IL-23) and immunoglobulin in peripheral plasma in patients with systemic lupus erythematosus (SLE). 【Methods】A total of 74 patients with systemic lupus erythematosus treated in our hospital were randomly divided into two groups (n=37). The control group was treated with prednisone acetate, while the observation group was treated with methotrexate on the basis of the control group. After three months of treatment, the clinical effects were evaluated. The immunoglobulin (IgA, IgG and IgM), IL-17, IL-23 and drug safety were compared between the two groups. 【Results】The levels of IgM, IgG and IgA in the observation group were higher than those in the control group at 3 months after treatment (P<0.05), while the levels of IL-17 and IL-23 in the observation group were lower than those in the control group at 3 months after treatment (P<0.05). There were no significant differences in gastrointestinal reactions, liver and kidney function damage between the observation group and the control group during treatment (P>0.05). 【Conclusion】Prednisone combined with methotrexate can improve the level of immunoglobulin in patients with systemic lupus erythematosus, reduce the levels of IL-17 and IL-23, and do not increase adverse drug reactions.

Key words： Lupus Erythematosus Systemic/DT Prednisone/PD Inflammation Mediators Immunoglobulins

Received: 09 April 2019

PACS:

R593.241

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Chen-xia
	ZHU Guan-nan
	ZHAO Liao-liao

Cite this article:

WANG Chen-xia,ZHU Guan-nan,ZHAO Liao-liao. Effects of Prednisone Combined with Methotrexate on Expression of Cytokines and Immunoglobulin IL-17 and IL-23 in Peripheral Blood of Patients with Systemic Lupus Erythematosus[J]. JOURNAL OF CLINICAL RESEARCH, 2021, 38(1): 19-21.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2021.01.006 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2021/V38/I1/19

[1] 何尚映,林洁,黄鹏,等.他克莫司胶囊联合醋酸泼尼松龙片治疗系统性红斑狼疮的临床研究[J].中国临床药理学杂志,2017,33(5):398-400.
[2] Hu SC,Yen FL,Wang TN,et al. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study[J].J Am Acad Dermatol,2016, 75(1):49-58.
[3] 夏金华,林万飞,谢丽燕,等.沙利度胺与泼尼松片分别联合来氟米特治疗对系统性红斑狼疮BAFF和IL-21的影响[J].中国实用医药,2016,11(26):198-199.
[4] 杨小静,黄传兵,刘轶菲,等.健脾滋肾法对系统性红斑狼疮的疗效及患者生活质量的影响[J].北京中医药大学学报,2016,39(1):77-81.
[5] 王治国,刘学明,佟胜全.糖皮质激素、环磷酰胺联合西地那非用于系统性红斑狼疮合并肺动脉高压患者临床效果观察[J].山东医药,2016,56(28):42-44.
[6] 张茉沁,高占成.以肺减缩综合征为首发表现的系统性红斑狼疮一例报告并文献复习[J].中国呼吸与危重监护杂志,2016(4):389-393.
[7] Durcan L,Winegar DA,Connelly MA,et al. Longitudinal evaluation of lipoprotein variables in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy[J].J Rheumatol,2016, 43(4):745.
[8] 杨朝美,李丽娟,吴军伟.解毒滋阴方辅助治疗系统性红斑狼疮的临床疗效及对淋巴细胞亚群和补体水平的影响[J].中药材,2016,39(6):1425-1427.
[9] 张庆,邵毅,关晏星.标准剂量泼尼松联合谷氨酰胺对~¹³¹I治疗后Graves眼病的保护作用[J].重庆医学,2017,46(13):1775-1778.
[10] 杨蓉. 黄芪注射液联合赖诺普利胶囊和醋酸泼尼松片治疗急性肾病综合征的临床研究[J].中国临床药理学杂志,2016,32(20):1852-1855.